Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
An Innovative Solution for Confocal Super Resolution
Wednesday, October 01, 2014
With the new Olympus FV-OSR software, the FluoView FV1200 is transformed into a powerful system for confocal Super Resolution microscopy.

Agilent Technologies’ Next-Generation UHPLC System
Tuesday, September 30, 2014
The 1290 Infinity II LC system sets new benchmark in laboratory efficiency.

New Mosaic 6.0 Makes Sample Management More Intuitive and Cost-effective
Tuesday, September 30, 2014
Latest version of Titian’s Mosaic software drives major increase in sample management efficiency.

Pexip® Introduces Infinity Connect
Friday, September 19, 2014
Visual meetings on any device simplified with installable client software supporting major desktop operating systems and all major browsers.

Need to Cut Patient Readmissions? There's an App for That
Friday, September 12, 2014
Aridhia transforms Nuffield’s readmission risk model into an online app designed to reduce number of patients readmitted to hospital within 30 days.

Artel Expands Software Development and Support Team
Thursday, September 11, 2014
Greg Fischer joins Company as software project manager.

New GC-MS Runs Both Single and Triple Quadrupole Methods Using Familiar Software
Monday, September 08, 2014
Labs have new option with the Thermo Scientific TSQ Duo triple quadrupole GC-MS/MS system.

Eagle Genomics Launches Eaglecore™
Saturday, September 06, 2014
New software platform will improve bioinformatics research.

Linguamatics I2E Semantic Enrichment Named as a KMWorld 2014 Trend-setting Product
Friday, September 05, 2014
Brings powerful semantic and natural language processing (NLP) technology.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 879
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn